Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022
Isoray, Inc. (NYSE AMERICAN: ISR) will host a conference call on May 10, 2022, at 4:30 p.m. ET to discuss its financial results for Q3 fiscal 2022, ending March 31, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray, Inc. (NYSE AMERICAN: ISR) will host a conference call on May 10, 2022, at 4:30 p.m. ET to discuss its financial results for Q3 fiscal 2022, ending March 31, 2022. A press release detailing these results will be issued after market close on the same day.
Participants can join the call by dialing (888) 506-0062, or (973) 528-0011 for international callers. The call will be accessible via webcast, available at this link until August 10, 2022.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was +1.20%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, Wash., April 29, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a conference call to discuss its financial results for the third quarter fiscal 2022 ended March 31, 2022 on Tuesday, May 10, 2022, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the third quarter fiscal year 2022 after the close of the U.S. stock markets on Tuesday, May 10, 2022.
To listen to the conference call, please dial (888) 506-0062. For callers outside the U.S., please dial (973) 528-0011.
The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/45391. The webcast will be available until August 10, 2022 following the conference call.
About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.